ORIENT GENE COVID19 AG 20 TESTS
36.80€
- Brand: LEADING MED Srl
- Product Code: 983301882
- EAN:
- Availability: Out Of Stock
- Purchase 3 items for 36.06€ each
- Purchase 4 items for 35.33€ each
- Purchase 5 items for 34.59€ each
Coronavirus Ag Rapid Test
Cassettes (Swabs)
PROFESSIONAL USE
Description
In vitro immunochromatographic test for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab (NP) or nasal swab specimens collected directly from individuals suspected of having COVID-19 by healthcare personnel within the first ten days of symptom onset and asymptomatic individuals.
The purpose is to aid in the rapid diagnosis of SARS-CoV-2 infections.
It is a membrane chromatographic immunoassay that uses highly sensitive monoclonal antibodies to detect the nucleocapsid protein from SARS-CoV-2 in nasopharyngeal swab (NP) or nasal swab.
The test strip consists of the following parts: sample pad, reagent pad, reaction membrane and absorbent pad. The reagent pad contains the orocolloid conjugated with the monoclonal antibodies against the SARS-CoV-2 nucleocapsid protein; the reaction membrane contains secondary antibodies to the SARS-CoV-2 protein nucleocapsid. The whole strip is fixed inside a plastic device.
When the sample is added to the sample well, the dried conjugates in the reagent buffer are dissolved and migrate with the sample. If SARS-CoV-2 nuclear capsid antigen is present in the specimen, a complex form between the anti-SARS-2 conjugate and the virus will be captured by the specific anti-SARS-2 monoclonal antibodies coated on the test line region (T).
The absence of the test line (T) suggests a negative result. Negative results from patients with symptom onset beyond ten days should be treated as presumed and confirmation can be made by molecular testing, if necessary for patient management.
To serve as a procedural control, a red line will always appear in the control line region (C) indicating that the appropriate volume of specimen has been added and membrane drainage has occurred.
The Coronavirus Ag Rapid Test Cassette (Swab) does not distinguish between SARS-CoV and SARS-CoV-2.
It is intended for use by healthcare professionals or trained operators who are competent in performing rapid tests and trained clinical laboratory personnel specifically trained in in vitro diagnostic procedures and proper infection control procedures, or by similarly trained individuals in point-of-care environments.
How to use
1. Sample collection :
Nasopharyngeal swab: Using the sterile nasopharyngeal swab provided in the kit, carefully insert the swab into the patient's nostril. Pass the swab on the surface of the posterior nasopharynx by rotating it several times. Remove the swab from the nasal cavity.
Nasal swab: Using the sterile swab provided in the kit, carefully insert the swab into one nostril of the patient. The swab tip should be inserted 2-4 cm until resistance is met. Roll the swab 5 times along the mucous membrane inside the nostril to ensure that both mucus and cells are collected. Using the same swab, repeat this process for the other nostril to ensure that an adequate sample is collected from both nasal cavities. Withdraw the swab from the nasal cavity. The sample is now ready for preparation using the extraction buffer provided in the test kit.
2. Sample Preparation Procedure :
Insert the test extraction tube into the workstation provided with the kit. Make sure the tube is upright and reaches the bottom of the workstation. Carefully remove the sealing film
In vitro immunochromatographic test for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal swab (NP) or nasal swab specimens collected directly from individuals suspected of having COVID-19 by healthcare personnel within the first ten days of symptom onset and asymptomatic individuals.
The purpose is to aid in the rapid diagnosis of SARS-CoV-2 infections.
It is a membrane chromatographic immunoassay that uses highly sensitive monoclonal antibodies to detect the nucleocapsid protein from SARS-CoV-2 in nasopharyngeal swab (NP) or nasal swab.
The test strip consists of the following parts: sample pad, reagent pad, reaction membrane and absorbent pad. The reagent pad contains the orocolloid conjugated with the monoclonal antibodies against the SARS-CoV-2 nucleocapsid protein; the reaction membrane contains secondary antibodies to the SARS-CoV-2 protein nucleocapsid. The whole strip is fixed inside a plastic device.
When the sample is added to the sample well, the dried conjugates in the reagent buffer are dissolved and migrate with the sample. If SARS-CoV-2 nuclear capsid antigen is present in the specimen, a complex form between the anti-SARS-2 conjugate and the virus will be captured by the specific anti-SARS-2 monoclonal antibodies coated on the test line region (T).
The absence of the test line (T) suggests a negative result. Negative results from patients with symptom onset beyond ten days should be treated as presumed and confirmation can be made by molecular testing, if necessary for patient management.
To serve as a procedural control, a red line will always appear in the control line region (C) indicating that the appropriate volume of specimen has been added and membrane drainage has occurred.
The Coronavirus Ag Rapid Test Cassette (Swab) does not distinguish between SARS-CoV and SARS-CoV-2.
It is intended for use by healthcare professionals or trained operators who are competent in performing rapid tests and trained clinical laboratory personnel specifically trained in in vitro diagnostic procedures and proper infection control procedures, or by similarly trained individuals in point-of-care environments.
How to use
1. Sample collection :
Nasopharyngeal swab: Using the sterile nasopharyngeal swab provided in the kit, carefully insert the swab into the patient's nostril. Pass the swab on the surface of the posterior nasopharynx by rotating it several times. Remove the swab from the nasal cavity.
Nasal swab: Using the sterile swab provided in the kit, carefully insert the swab into one nostril of the patient. The swab tip should be inserted 2-4 cm until resistance is met. Roll the swab 5 times along the mucous membrane inside the nostril to ensure that both mucus and cells are collected. Using the same swab, repeat this process for the other nostril to ensure that an adequate sample is collected from both nasal cavities. Withdraw the swab from the nasal cavity. The sample is now ready for preparation using the extraction buffer provided in the test kit.
2. Sample Preparation Procedure :
Insert the test extraction tube into the workstation provided with the kit. Make sure the tube is upright and reaches the bottom of the workstation. Carefully remove the sealing film